Lancet Review Warns of Public Health Risks From Cannabis Legalization

A Lancet review synthesized evidence on adverse public health effects linked to cannabis legalization, including increased emergency visits, impaired driving, and youth exposure.

Mekonen Yimer, Tesfa et al.·The Lancet. Public health·2025·Strong EvidenceReview
RTHC-07114ReviewStrong Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Strong Evidence
Sample
Not reported

What This Study Found

The review found that cannabis legalization has been associated with several adverse public health outcomes including increased emergency department visits, cannabis-impaired driving incidents, and accidental pediatric exposures, though effects vary by jurisdiction and policy design.

Key Numbers

Review synthesizes data across multiple jurisdictions; specific figures from individual studies cited in full text.

How They Did This

Comprehensive review published in The Lancet synthesizing evidence from multiple jurisdictions on the adverse public health consequences of cannabis legalization.

Why This Research Matters

As more countries and states consider legalization, understanding the documented downsides is essential for designing policies that maximize benefits while minimizing harm.

The Bigger Picture

The legalization debate often focuses on criminal justice reform and tax revenue. This review centers the public health evidence, providing a counterweight that policymakers need to consider alongside potential benefits.

What This Study Doesn't Tell Us

Reviews depend on the quality and comparability of underlying studies. Jurisdictions differ widely in regulatory frameworks, making generalization difficult. Some negative trends may reflect better surveillance rather than true increases.

Questions This Raises

  • ?Can smarter regulatory design mitigate the adverse effects identified?
  • ?How do the public health costs compare to the harms of prohibition?
  • ?Which populations are most vulnerable?

Trust & Context

Key Stat:
Lancet review links legalization to increased ER visits and impaired driving
Evidence Grade:
Published in a top-tier journal, synthesizing evidence across jurisdictions, though underlying study quality varies.
Study Age:
2025 review capturing the most current evidence on legalization outcomes.
Original Title:
The adverse public health effects of non-medical cannabis legalisation in Canada and the USA.
Published In:
The Lancet. Public health, 10(2), e148-e159 (2025)
Database ID:
RTHC-07114

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Does cannabis legalization cause public health problems?

This Lancet review found legalization has been associated with increased emergency visits, impaired driving, and accidental pediatric exposures, though the magnitude varies by how each jurisdiction regulates cannabis.

Are the health risks of legalization worse than prohibition?

The review focused on documenting adverse effects rather than comparing them to prohibition harms. A full cost-benefit analysis would need to weigh both sides.

Read More on RethinkTHC

Cite This Study

RTHC-07114·https://rethinkthc.com/research/RTHC-07114

APA

Mekonen Yimer, Tesfa; Hoch, Eva; Fischer, Benedikt; Dawson, Danielle; Hall, Wayne. (2025). The adverse public health effects of non-medical cannabis legalisation in Canada and the USA.. The Lancet. Public health, 10(2), e148-e159. https://doi.org/10.1016/S2468-2667(24)00299-8

MLA

Mekonen Yimer, Tesfa, et al. "The adverse public health effects of non-medical cannabis legalisation in Canada and the USA.." The Lancet. Public health, 2025. https://doi.org/10.1016/S2468-2667(24)00299-8

RethinkTHC

RethinkTHC Research Database. "The adverse public health effects of non-medical cannabis le..." RTHC-07114. Retrieved from https://rethinkthc.com/research/mekonen-2025-the-adverse-public-health

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.